natural killer cells from patients with recombinase-activating gene and non-homologous end joining gene defects comprise a higher frequency of cd56bright nkg2a+++ cells, and yet display increased degranulation and higher perforin content

Clicks: 318
ID: 167704
2017
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #193 of 644 articles by views in sudebno-meditsinskaia ekspertiza

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 644 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Mutations of the recombinase-activating genes 1 and 2 (RAG1 and RAG2) in humans are associated with a broad range of phenotypes. For patients with severe clinical presentation, hematopoietic stem cell transplantation (HSCT) represents the only curative treatment; however, high rates of graft failure and incomplete immune reconstitution have been observed, especially after unconditioned haploidentical transplantation. Studies in mice have shown that Rag−/− natural killer (NK) cells have a mature phenotype, reduced fitness, and increased cytotoxicity. We aimed to analyze NK cell phenotype and function in patients with mutations in RAG and in non-homologous end joining (NHEJ) genes. Here, we provide evidence that NK cells from these patients have an immature phenotype, with significant expansion of CD56bright CD16−/int CD57− cells, yet increased degranulation and high perforin content. Correlation was observed between in vitro recombinase activity of the mutant proteins, NK cell abnormalities, and in vivo clinical phenotype. Addition of serotherapy in the conditioning regimen, with the aim of depleting the autologous NK cell compartment, may be important to facilitate engraftment and immune reconstitution in patients with RAG and NHEJ defects treated by HSCT.
Reference Key
dobbs2017frontiersnatural Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Kerry Dobbs;Giovanna Tabellini;Enrica Calzoni;Ornella Patrizi;Paula Martinez;Silvia Clara Giliani;Daniele Moratto;Waleed Al-Herz;Caterina Cancrini;Caterina Cancrini;Morton Cowan;Jacob Bleesing;Claire Booth;David Buchbinder;Siobhan O. Burns;Siobhan O. Burns;Talal A. Chatila;Janet Chou;Vanessa Daza-Cajigal;Lisa M. Ott de Bruin;Maite Teresa de la Morena;Gigliola Di Matteo;Gigliola Di Matteo;Andrea Finocchi;Andrea Finocchi;Raif Geha;Rakesh K. Goyal;Anthony Hayward;Steven Holland;Chiung-Hui Huang;Maria G. Kanariou;Alejandra King;Blanka Kaplan;Anastasiya Kleva;Taco W. Kuijpers;Bee Wah Lee;Vassilios Lougaris;Michel Massaad;Isabelle Meyts;Megan Morsheimer;Benedicte Neven;Sung-Yun Pai;Nima Parvaneh;Nima Parvaneh;Alessandro Plebani;Susan Prockop;Ismail Reisli;Jian Yi Soh;Raz Somech;Troy R. Torgerson;Yae-Jaen Kim;Jolan E. Walter;Andrew R. Gennery;Andrew R. Gennery;Sevgi Keles;John P. Manis;Emanuela Marcenaro;Alessandro Moretta;Silvia Parolini;Luigi D. Notarangelo
Journal sudebno-meditsinskaia ekspertiza
Year 2017
DOI
10.3389/fimmu.2017.00798
URL
http://journal.frontiersin.org/article/10.3389/fimmu.2017.00798/full
Keywords
natural killer cells immunodeficiency allergy non-homologous end joining

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.